NDC codes

370405 NDC codes with hospital pricing data in the network.

• NDC 00083-5812-96 — Dibucaine 1% rectal ointmentAI (13 hospitals, 456 samples)
• NDC 00378-6009-01 — Fluphenazine 2.5 mg oral tabletAI (29 hospitals, 456 samples)
• NDC 65219-0082-01 — Gadoterate meglumine contrast injectionAI (49 hospitals, 456 samples)
• NDC 09999-4084-42 — Technetium-99m mebrofenin imaging agentAI (44 hospitals, 141–456 samples)
• NDC 55390-0126-05 — Midazolam injection, 5 mg/mL, 5 mL vialAI (26 hospitals, 60–456 samples)
• NDC 54288-0136-10 — Phenobarbital sodium injectionAI (123 hospitals, 131–455 samples)
• NDC 338067104 — Dextrose and half-normal saline with potassium, 1,000 mL bagAI (179 hospitals, 85–454 samples)
• NDC 00641-1397-31 — Chlorpromazine 25 mg/mL injectionAI (484 hospitals, 58–454 samples)
• NDC 264752000 — Dextrose 10% solution, 1,000 mL bagAI (123 hospitals, 220–454 samples)
• NDC 50090-1841-00 — DIPHENHYDRAMINE PER 50 MG (7 hospitals, 382–454 samples)
• NDC 407222323 — Iodixanol contrast dye, 500 mL bottleAI (42 hospitals, 418–454 samples)
• NDC 15082-0901-05 — MAGNESIUM SULFATE 1 GRAM/50 ML IN DEXTROSE 5 % INTRAVENOUS PIGGYBACK (7 hospitals, 435–453 samples)
• NDC 70860-0402-41 — Bivalirudin 250 mg IV powder for solutionAI (195 hospitals, 219–453 samples)
• NDC 71288-0427-11 — Bivalirudin 250 mg vial for injectionAI (373 hospitals, 129–453 samples)
• NDC 61755-0005-02 — Aflibercept 2 mg/0.05 mL vialAI (228 hospitals, 201–453 samples)
• NDC 409189013 — Morphine 2 mg/mL injection syringeAI (34 hospitals, 156–453 samples)
• NDC 72572-0029-01 — VANCOMYCIN 1,000 MG INTRAVENOUS INJECTION (7 hospitals, 228–453 samples)
• NDC 00228-3156-03 — Buprenorphine 2 mg sublingual tabletAI (183 hospitals, 56–452 samples)
• NDC 17478-0501-01 — Methylergonovine injectionAI (138 hospitals, 65–452 samples)
• NDC 17478-0631-10 — Fluoresc-Benox 0.25-0.4% Opth Soln 5 mL (5 hospitals, 407–452 samples)
• NDC 00781-6135-95 — Penicillin G potassium injection, 1 million units per 10 mLAI (250 hospitals, 56–452 samples)
• NDC 70700-0902-25 — Glycopyrrolate injection, 0.2 mg/mL, 5 mL vialAI (34 hospitals, 200–452 samples)
• NDC 70700-0902-22 — Glycopyrrolate injection 0.2 mg/mL, 5 mL vialAI (36 hospitals, 200–452 samples)
• NDC 00781-2104-01 — Tacrolimus 5 mg immediate-release capsuleAI (202 hospitals, 271–451 samples)
• NDC 00407-2943-12 — Gadoterate meglumine contrast injection, 10 mLAI (41 hospitals, 433–451 samples)
• NDC 73463-0103-06 — Ketamine 30 mg in 6 mL syringeAI (12 hospitals, 424–451 samples)
• NDC 42806-0400-01 — METHYLPREDNISOLONE 4 MG TABLETAI (222 hospitals, 45–450 samples)
• NDC 00143-9209-10 — Chloroprocaine hydrochloride 2% injectionAI (309 hospitals, 144–450 samples)
• NDC 69918-0899-10 — Desmopressin acetate injection, preservative-free, 4 mcg/mLAI (733 hospitals, 144–450 samples)
• NDC 00338-0063-01 — Doxil 2 mg/mL IV suspensionAI (400 hospitals, 189–450 samples)
• NDC 00006-0267-06 — RIZATRIPTAN 10MG TAB (5 hospitals, 432–450 samples)
• NDC 00071-0181-24 — Phenazopyridine 200 mg Tab (7 hospitals, 369–450 samples)
• NDC 00093-0233-19 — Oral antiemetic medication, unspecifiedAI (15 hospitals, 216–450 samples)
• NDC 70069-0641-01 — ATROPINE 1 MG/ML INTRAVENOUS SOLUTIONAI (121 hospitals, 117–450 samples)
• NDC 00143-9310-10 — Etomidate injection 2 mg/mL, 10 mL vialAI (126 hospitals, 243–450 samples)
• NDC 42023-0219-10 — Vasostrict IV solution (vasopressin)AI (118 hospitals, 243–450 samples)
• NDC 0002751001 — Insulin lispro injection solutionAI (54 hospitals, 45–450 samples)
• NDC 0002751017 — Insulin lispro injection solutionAI (62 hospitals, 45–450 samples)
• NDC 0002751101 — Insulin lispro protamine mix, 75/25 subcutaneous suspensionAI (47 hospitals, 45–450 samples)
• NDC 0002751201 — Insulin lispro protamine mix, 100 units per mLAI (20 hospitals, 45–450 samples)
• NDC 0002821501 — Regular human insulin injection, 100 units per mLAI (70 hospitals, 45–450 samples)
• NDC 0002821517 — Regular human insulin injection solutionAI (34 hospitals, 45–450 samples)
• NDC 0002831501 — Isophane insulin (NPH), 100 units per mL injectable suspensionAI (66 hospitals, 45–450 samples)
• NDC 0002831517 — Human NPH insulin, 100 units/mL injectionAI (48 hospitals, 45–450 samples)
• NDC 0002831591 — Insulin NPH isophane human 100 units per mL suspensionAI (20 hospitals, 45–450 samples)
• NDC 0002871501 — Human insulin NPH and regular 70/30 mix injectionAI (45 hospitals, 45–450 samples)
• NDC 0002871517 — Insulin NPH and regular mix, 70/30AI (51 hospitals, 45–450 samples)
• NDC 0024592605 — Insulin lispro injection solutionAI (55 hospitals, 45–450 samples)
• NDC 0169183311 — Regular human insulin injection, 100 units per mLAI (43 hospitals, 45–450 samples)
• NDC 0169183402 — NPH insulin isophane human 100 units per mLAI (20 hospitals, 45–450 samples)